The US Air Force Nuclear Weapons Center (AFNCW) on 23 August disclosed separate cost-plus-fixed-fee contract awards – each valued at “approximately USD900 million” – to Lockheed Martin and Raytheon for the technology maturation and risk reduction (TMRR) phase in the development of the air force’s prospective air-launched Long-Range Stand Off (LRSO) nuclear weapon.
The TMRR phase is a critical step in advancing the technologies, systems, and subsystems for the LRSO programme, prior to its engineering, manufacturing and development milestone, which is expected in 2022.
LRSO is being developed to replace the AGM-86B nuclear-armed air-launched cruise missile (ALCM) and is expected to be fielded by the US Air Force (USAF) by 2030.
Want to read more? For analysis on this article and access to all our insight content, please enquire about our subscription options: ihs.com/contact